Trends in use of surgical mesh for pelvic organ prolapse

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 1, 2013, Pages 79.e1-79.e7

  Jonsson Funk, Michele ^a,b   Edenfield, Autumn L ^c   Pate, Virginia ^a   Visco, Anthony G ^c   Weidner, Alison C ^c   Wu, Jennifer M ^c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

pelvic organ prolapse; sacrocolpopexy; surgery; transvaginal mesh; trends

Indexed keywords

ABDOMINAL SACROCOLPOPEXY; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SACROCOLPOPEXY; PATIENT SAFETY; PELVIC ORGAN PROLAPSE; PRIORITY JOURNAL; SURGICAL MESH; TRANSVAGINAL SLING; UNITED STATES;

EID: 84871565238     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.11.008     Document Type: Article

References (28)

1. Food and Drug Administration Safety communication: update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse Issued July 13, 2011 http://www.fda.gov/medicaldevices/safety/ alertsandnotices/ucm262435.htm Accessed June 12, 2012
2. Food and Drug Administration Public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse Issued Oct. 20, 2008 http://www.fda.gov/medicaldevices/ safety/alertsandnotices/publichealthnotifications/ucm061976.htm Accessed June 12, 2012
3. American College of Obstetricians and Gynecologists and American Urogynecology Society Committee opinion no. 513: vaginal placement of synthetic mesh for pelvic organ prolapse Obstet Gynecol 118 2011 1459 1464
4. Food and Drug Administration 510(k) premarket notification, no. K040537 American Medical Systems Apogee vault suspension system http://www.accessdata. fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=14536 Accessed June 12, 2012
5. Food and Drug Administration 510(k) Premarket notification, no. K040623 American Medical Systems Perigee system http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfPMN/pmn.cfm?ID=14611 Accessed June 12, 2012
6. Food and Drug Administration Executive summary: surgical mesh for the treatment of women with pelvic organ prolapse and stress urinary incontinence, Sept. 8-9, 2011 http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ ObstetricsandGynecologyDevices/UCM270402.pdf Accessed June 12, 2012
7. S.H. Boyles, A.M. Weber, L. Meyn Procedures for pelvic organ prolapse in the United States, 1979-1997 Am J Obstet Gynecol 188 2003 108 115
8. E.A. Erekson, V.V. Lopes, C.A. Raker, V.W. Sung Ambulatory procedures for female pelvic floor disorders in the United States Am J Obstet Gynecol 203 2010 497.e1 497.e5
9. K.A. Jones, J.P. Shepherd, S.S. Oliphant, L. Wang, C.H. Bunker, J.L. Lowder Trends in inpatient prolapse procedures in the United States, 1979-2006 Am J Obstet Gynecol 202 2010 501.e1 501.e7
10. S.L. Bradley, A.C. Weidner, N.Y. Siddiqui, M.P. Gandhi, J.M. Wu Shifts in national rates of inpatient prolapse surgery emphasize current coding inadequacies Female Pelvic Med Reconstr Surg 17 2011 204 208
11. Centers for Disease Control and Prevention Classification of diseases, conversion table of new ICD-9-CM codes, October 2011 http://www.cdc.gov/nchs/ data/icd9/CNVTB12.pdf Accessed June 26, 2012
12. Thomson Reuters MarketScan Commercial Claims and Encounters Database, 2000-2009 Source: Red Book and MarketScan are registered trademarks of Thomson Reuters (Healthcare) Inc http://thomsonreuters.com/products-services/healthcare/ healthcare-products/pharmaceuticals/mktscan-res-db/ Accessed June 12, 2012
13. C. Denavas-Walt, B.D. Proctor, J.C. Smith US Census Bureau, current population reports, P60-239, income, poverty, and health insurance coverage in the United States: 2010 2011 US Government Printing Office Washington, DC http://www.census.gov/prod/2011pubs/p60-239.pdf Accessed June 24, 2012
14. Center for Medicare and Medicaid Services January 2005 update to the Medicare non-OPPS Outpatient Code Editor (OCE) specifications version 20.1 for bills from hospitals not paid under the Outpatient Prospective Payment Systems (OPPS), MLN Matters number MM3621 https://www.cms.gov/Outreach-and-Education/ Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM3621.pdf Accessed June 26, 2012
15. K. Nieminen, R. Hiltunen, T. Takala Outcomes after anterior vaginal wall repair with mesh: a randomized, controlled trial with a 3 year follow-up Am J Obstet Gynecol 203 2010 235.e1 235.e8
16. D. Altman, T. Vayrynen, M.E. Engh, S. Axelsen, C. Falconer Short-term outcome after transvaginal mesh repair of pelvic organ prolapse Int Urogynecol J Pelvic Floor Dysfunct 19 2008 787 793
17. C.H. Nezhat, F. Nezhat, C. Nezhat Laparoscopic sacral colpopexy for vaginal vault prolapse Obstet Gynecol 84 1994 885 888
18. D.S. Elliott, I. Frank, D.S. Dimarco, G.K. Chow Gynecologic use of robotically assisted laparoscopy: sacrocolpopexy for the treatment of high-grade vaginal vault prolapse Am J Surg 188 2004 52S 56S
19. D.S. DI Marco, G.K. Chow, M.T. Gettman, D.S. Elliott Robotic-assisted laparoscopic sacrocolpopexy for treatment of vaginal vault prolapse Urology 63 2004 373 376
20. Food and Drug Administration 510(k) premarket notification, no. K050404 Intuitive surgical da Vinci surgical system and endoscopic instruments http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=17591 Accessed June 26, 2012
21. J.M. Wu, E.C. Wells, A.F. Hundley, A. Connolly, K.S. Williams, A.G. Visco Mesh erosion in abdominal sacral colpopexy with and without concomitant hysterectomy Am J Obstet Gynecol 194 2006 1418 1422
22. P.A. Nosti, J.K. Lowman, T.W. Zollinger, D.S. Hale, P.J. Woodman Risk of mesh erosion after abdominal sacral colpoperineopexy with concomitant hysterectomy Am J Obstet Gynecol 201 2009 541.e1 541.e4
23. G.W. Cundiff, E. Varner, A.G. Visco Risk factors for mesh/suture erosion following sacral colpopexy Am J Obstet Gynecol 199 2008 688.e1 688.e5
24. N.Y. Siddiqui, E.J. Geller, A.G. Visco Symptomatic and anatomic 1-year outcomes after robotic and abdominal sacrocolpopexy Am J Obstet Gynecol 206 2012 435.e1 435.e5
25. B.C. Osmundsen, A. Clark, C. Goldsmith Mesh erosion in robotic sacrocolpopexy Female Pelvic Med Reconstr Surg 18 2012 86 88
26. A.C. Frick, M.D. Walters, K.S. Larkin, M.D. Barber Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse Am J Obstet Gynecol 202 2010 507.e1 507.e4
27. O. Ramm, J.L. Gleason, S. Segal, D.D. Antosh, K.S. Kenton Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction Int Urogynecol J 23 2012 913 917
28. J.S. Brown, L.E. Waetjen, L.L. Subak, D.H. Thom, S. Van Den Eeden, E. Vittinghoff Pelvic organ prolapse surgery in the United States, 1997 Am J Obstet Gynecol 186 2002 712 716